Alexithymia Intervention for Suicide
NCT05724953
Summary
Suicide rates among Veterans with Serious Mental Illness (SMI) are intractably high, representing a serious public health concern and a critical target for interventions. Yet, at present available treatments offer modest benefits. Thus, there remains an urgent need to identify novel approaches to address suicide risk in this population. Previous reports have linked suicide risk with poor social functioning. Emerging evidence from basic affective neuroscience research has indicated that effective social functioning is contingent on intact emotion awareness. Consistent with these findings, individuals with SMI at risk of suicide display social functioning difficulties along with poor emotion awareness (i.e., alexithymia). Employing a proof-of-concept design, the aim of the present study is to test the feasibility and acceptability of a novel, blended psychoeducation and digital mHealth (mobile health) intervention with smartphones designed to target alexithymia and poor social functioning to reduce suicide risk in Veterans with SMI.
Eligibility
Inclusion Criteria: * a DSM-V diagnosis of PTSD * bipolar disorder * MDD * schizophrenia * at risk of suicide(Columbia Suicide Severity Rating Scale * C-SSRS \>=3 or a suicide attempt in the past 5 years) * limited emotion awareness (Toronto Alexithymia Scale; TAS-20 \>=52) * can understand all the study's risks and benefits Exclusion Criteria: * have medical/neurological conditions that could interfere with study participation * enrolled in another treatment study * unable/unwilling to provide a verifiable contact for emergency purposes
Conditions6
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05724953